Skip to main content

and
  1. No Access

    Article

    A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology

    Diabetic cardiomyopathy describes heart disease in patients with diabetes who have no other cardiac conditions but have a higher risk of develo** heart failure. Specific therapies to treat the diabetic heart...

    Kate L. Weeks, Helen Kiriazis, Glenn D. Wadley in Journal of Molecular Medicine (2024)

  2. Article

    Open Access

    Elevated myocardial fructose and sorbitol levels are associated with diastolic dysfunction in diabetic patients, and cardiomyocyte lipid inclusions in vitro

    Diabetes is associated with cardiac metabolic disturbances and increased heart failure risk. Plasma fructose levels are elevated in diabetic patients. A direct role for fructose involvement in diabetic heart p...

    Lorna J. Daniels, Marco Annandale, Parisa Koutsifeli, Xun Li in Nutrition & Diabetes (2021)

  3. Article

    Myocardial Gene Expression Associated with Genetic Cardiac Hypertrophy in the Absence of Hypertension

    The hypertrophic heart rat (HHR) was derived from the spontaneously hypertensive rat of the Okamoto strain and develops cardiac hypertrophy in the absence of hypertension. The genetic basis of this hypertrophy...

    Jeremy P Dwyer, Matthew E Ritchie, Gordon K Smyth in Hypertension Research (2008)